Neal C Bradsher Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity
Neal C Bradsher is Director of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 87,628 shares of LCTX, which is worth approximately $49,071. The most recent transaction as insider was on Jun 25, 2021, when has been sold 24,720 shares (Common Shares) at a price of $2.2 per share, resulting in proceeds of $54,384. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
87.6K
0%
3M change
0%
12M change
Total Value Held
$49,071
NCB
Neal C Bradsher
Director
New York, NY